The Impact of BMI and Hormonal Contraception on Menstrual Abnormalities: A Cross-Sectional Analysis

  • Alexandria Firdaus Al-Farisy Puskesmas Kedungjati, Kabupaten Grobongan Jawa Tengah, Indonesia
Keywords: Hormonal Contraception, Menstrual Abnormalities, Body Mass Index

Abstract

Hormonal contraception and body mass index (BMI) have been linked to menstrual irregularities, yet the nature of this relationship remains unclear. A cross-sectional study was conducted among0020a sample of 138 women who were using hormonal contraception. Data was collected through self-administered questionnaires. The participants were grouped based on type and duration of hormonal contraception use (combined contraceptives and progestin contraception) and their BMI was calculated based on their height and weight measurements. Menstrual abnormalities were recorded through the participants' self-reported data. Data was analysed using descriptive statistics, chi-square tests, and logistic regression models. Results showed that there was a significant difference in menstrual abnormalities between different types of hormonal contraception p=0.021, OR=2.398,  Women who used progestin only contraception had a higher risk of developing menstrual abnormalities than combined contraceptives. There was significance different of duration of use hormonal contraception with menstrual abnormalities p=0.037, OR=2.312 for a long duration (more than 1 years) compared to less than one year. Women with a higher BMI (greater than 25 kg/m2) p=0.038, OR=2.169 had a significant risk of developing menstrual abnormalities. The study concludes that the type and duration of hormonal contraception use and BMI play a significant role in the development of menstrual abnormalities. Women should be informed about the potential risks and benefits of different types of hormonal contraception and the importance of maintaining a healthy BMI. Healthcare providers should consider these factors when making recommendations for hormonal contraception.

References

Anastasiou, E., McCarthy, K. J., Gollub, E. L., Ralph, L., van de Wijgert, J. H. H. M., & Jones, H. E. (2022). The relationship between hormonal contraception and cervical dysplasia/cancer controlling for human papillomavirus infection: A systematic review. Contraception, 107, 1–9. https://doi.org/10.1016/j.contraception.2021.10.018

Bachmann, G., & Korner, P. (2009). Bleeding patterns associated with non-oral hormonal contraceptives: a review of the literature. Contraception, 79(4), 247–258. https://doi.org/10.1016/j.contraception.2008.10.012

Effendi, K. Y., Nasrul, E., Zulqarnain, I., Theodorus, Amran, R., Manan, H., Abadi, A., Usman, F., & Kesty, C. (2023). Diagnostic Test of Transforming Growth Factor-Beta 1 (TGF-β1) in Menstrual Blood with Endometriosis. Obstetrics and Gynecology International, 2023, 1–6. https://doi.org/10.1155/2023/9970818

Harlow, S. D., & Campbell, O. M. R. (2004). Epidemiology of menstrual disorders in developing countries: a systematic review. BJOG: An International Journal of Obstetrics & Gynaecology, 111(1), 6–16. https://doi.org/10.1111/j.1471-0528.2004.00012.x

Itriyeva, K. (2022). The effects of obesity on the menstrual cycle. Current Problems in Pediatric and Adolescent Health Care, 52(8), 101241. https://doi.org/10.1016/j.cppeds.2022.101241

Ivanova, O., Rai, M., & Kemigisha, E. (2018). A Systematic Review of Sexual and Reproductive Health Knowledge, Experiences and Access to Services among Refugee, Migrant and Displaced Girls and Young Women in Africa. International Journal of Environmental Research and Public Health, 15(8). https://doi.org/10.3390/ijerph15081583

Kurniawati, H., & Afifatul Latifah. (2022). Relationship between Hormonal Contraception and Menstrual Cycle. Bioscientia Medicina : Journal of Biomedicine and Translational Research, 6(8), 2069–2073. https://doi.org/10.37275/bsm.v6i8.546

Pandey, S., & Bhattacharya, S. (2010). Impact of Obesity on Gynecology. Women’s Health, 6(1), 107–117. https://doi.org/10.2217/WHE.09.77

Schumpf, L. F., Braun, C., Peric, A., Schmid, M. J., Lehnick, D., Christmann-Schmid, C., & Brambs, C. (2023). The influence of the menstrual cycle and hormonal contraceptives on cardiorespiratory fitness in physically active women: A systematic review and meta-analysis. Heliyon, 9(6), e17049. https://doi.org/10.1016/j.heliyon.2023.e17049

Shulman, L. P. (2000). Contraception 2000: LunelleTM, an Injectable Combination Contraceptive Option. Journal of Women’s Health & Gender-Based Medicine, 9(7), 725–729. https://doi.org/10.1089/15246090050147637

Sperrin, M., Marshall, A. D., Higgins, V., Renehan, A. G., & Buchan, I. E. (2016). Body mass index relates weight to height differently in women and older adults: serial cross-sectional surveys in England (1992–2011). Journal of Public Health, 38(3), 607–613. https://doi.org/10.1093/pubmed/fdv067

Trogstad, L., Laake, I., Robertson, A. H., Mjaaland, S., Caspersen, I. H., Juvet, L. K., Magnus, P., Blix, K., & Feiring, B. (2023). Heavy bleeding and other menstrual disturbances in young women after COVID-19 vaccination. Vaccine, 41(36), 5271–5282. https://doi.org/10.1016/j.vaccine.2023.06.088

Published
2024-02-05
How to Cite
Firdaus Al-Farisy, A. (2024). The Impact of BMI and Hormonal Contraception on Menstrual Abnormalities: A Cross-Sectional Analysis. Journal La Medihealtico, 5(1), 71-80. https://doi.org/10.37899/journallamedihealtico.v5i1.1044